Literature DB >> 6421975

Measurement of apolipoprotein A-I concentration in nonhuman primate serum by enzyme-linked immunosorbent assay (ELISA).

D L Koritnik, L L Rudel.   

Abstract

A sensitive and specific enzyme-linked immunosorbent assay (ELISA) for nonhuman primate serum apolipoprotein A-I (apoA-I) is described. The assay is a noncompetitive, sandwich ELISA in which polystyrene microtiter plates were used with purified, monospecific goat anti-monkey apoA-I antibodies adsorbed on the wells. The serum samples were added to the coated wells, incubated, and after washing, antibodies conjugated to horseradish peroxidase were added. After further washing, the bound label was assayed. A heat treatment step, 52 degrees C for 3 hr, was used to maximize the apoA-I immunoreactive sites in diluted serum. Serum samples extracted with chloroform-methanol, delipidated with tetramethylurea, or denatured by heating gave essentially equivalent results. The working range of the apoA-I standards was 0.5 to 5 ng and parallel responses were observed for apoA-I in serum, in isolated HDL, and in buffer as a purified apoprotein. Recovery of apoA-I added to serum was quantitative (106 +/- 3%). The intra- and interassay coefficients of variation were 6.2 and 6.9%, respectively. The enzyme immunoassay yielded values that compared favorably with those obtained by radial immunodiffusion (r = 0.84). ApoA-I concentration in African green monkey serum was highly correlated with the HDL cholesterol concentration (r = 0.86). It is concluded that this ELISA is an accurate and precise method for determination of apoA-I concentrations in primate serum.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6421975

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  11 in total

1.  Hepatic origin of cholesteryl oleate in coronary artery atherosclerosis in African green monkeys. Enrichment by dietary monounsaturated fat.

Authors:  L L Rudel; J Haines; J K Sawyer; R Shah; M S Wilson; T P Carr
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

2.  Dietary cholesterol and downregulation of cholesterol 7 alpha-hydroxylase and cholesterol absorption in African green monkeys.

Authors:  L Rudel; C Deckelman; M Wilson; M Scobey; R Anderson
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

3.  Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I.

Authors:  Jenelle M Timmins; Ji-Young Lee; Elena Boudyguina; Kimberly D Kluckman; Liam R Brunham; Anny Mulya; Abraham K Gebre; Jonathan M Coutinho; Perry L Colvin; Thomas L Smith; Michael R Hayden; Nobuyo Maeda; John S Parks
Journal:  J Clin Invest       Date:  2005-04-07       Impact factor: 14.808

4.  Hepatic apolipoprotein M (apoM) overexpression stimulates formation of larger apoM/sphingosine 1-phosphate-enriched plasma high density lipoprotein.

Authors:  Mingxia Liu; Jeongmin Seo; Jeremy Allegood; Xin Bi; Xuewei Zhu; Elena Boudyguina; Abraham K Gebre; Dorit Avni; Dharika Shah; Mary G Sorci-Thomas; Michael J Thomas; Gregory S Shelness; Sarah Spiegel; John S Parks
Journal:  J Biol Chem       Date:  2013-12-06       Impact factor: 5.157

5.  Plasma lipid transfer protein as a determinant of the atherogenicity of monkey plasma lipoproteins.

Authors:  E Quinet; A Tall; R Ramakrishnan; L Rudel
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

6.  Validation of human ApoB and ApoAI immunoturbidity assays for non-human primate dyslipidemia and atherosclerosis research.

Authors:  Zhu Chen; Alison M Strack; Alice C Stefanni; Ying Chen; Weizhen Wu; Yi Pan; Olga Urosevic-Price; Li Wang; Theresa McLaughlin; Neil Geoghagen; Michael E Lassman; Thomas P Roddy; Kenny K Wong; Brian K Hubbard; Amy M Flattery
Journal:  J Cardiovasc Transl Res       Date:  2011-03-11       Impact factor: 4.132

7.  Selective delipidation of plasma HDL enhances reverse cholesterol transport in vivo.

Authors:  Frank M Sacks; Lawrence L Rudel; Adam Conner; Hassibullah Akeefe; Gerhard Kostner; Talal Baki; George Rothblat; Margarita de la Llera-Moya; Bela Asztalos; Timothy Perlman; Chunyu Zheng; Petar Alaupovic; Jo-Ann B Maltais; H Bryan Brewer
Journal:  J Lipid Res       Date:  2009-01-14       Impact factor: 5.922

8.  Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys.

Authors:  J D Wagner; T B Clarkson; R W St Clair; D C Schwenke; C A Shively; M R Adams
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

9.  Dietary polyunsaturated fat decreases interaction between low density lipoproteins and arterial proteoglycans.

Authors:  J M Manning; A K Gebre; I J Edwards; W D Wagner; L L Rudel; J S Parks
Journal:  Lipids       Date:  1994-09       Impact factor: 1.880

10.  Increased cellular free cholesterol in macrophage-specific Abca1 knock-out mice enhances pro-inflammatory response of macrophages.

Authors:  Xuewei Zhu; Ji-Young Lee; Jenelle M Timmins; J Mark Brown; Elena Boudyguina; Anny Mulya; Abraham K Gebre; Mark C Willingham; Elizabeth M Hiltbold; Nilamadhab Mishra; Nobuyo Maeda; John S Parks
Journal:  J Biol Chem       Date:  2008-06-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.